CCMP Capital LLC
CCMP Capital LLC is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at CCMP Capital LLC.
CCMP Capital LLC is a company.
Key people at CCMP Capital LLC.
Key people at CCMP Capital LLC.
CCMP Capital is a New York-based private equity firm specializing in middle-market leveraged buyouts and growth capital investments, primarily in high-growth consumer, industrial, healthcare, and energy sectors.[1][2][3][4] With roots as J.P. Morgan's investment arm, it manages over $26 billion in assets globally through funds like CCMP Capital Investors III ($3.6B, closed 2014) and a $948M continuation vehicle (2022), emphasizing operational improvements and long-term value creation in North America, Europe, and Asia.[1][3] Its philosophy centers on partnering with proven management teams in established businesses, targeting resilient companies with strong cash flows, pricing power, and digital transformation potential to drive 10%+ organic growth and strategic add-ons.[1][4]
The firm impacts the startup and middle-market ecosystem by providing flexible capital ($50-200M equity per deal) to founder-led and family-owned platforms, enabling scale through modest leverage, add-on acquisitions (over 60 executed historically), and exits like IPOs or sales, fostering wealth-building for teams and strong returns for investors.[3][4]
CCMP Capital traces its roots to 1984 as Chemical Venture Partners, the private equity and venture capital arm of Chemical Bank, evolving through mergers into Manufacturers Hanover, Chase Capital Partners, and J.P. Morgan Partners.[2][3] In March 2005, J.P. Morgan Partners announced a spinout, completed on July 31, 2006, when investment professionals separated from JPMorgan Chase, adopting the CCMP name (referencing Chemical, Chase, and J.P. Morgan Partners).[1][2] The firm has since focused on buyouts and growth equity, investing ~$12-16 billion across transactions, including selling Medpace for $900M in 2014 and acquiring Badger Sportswear in 2016.[2][3]
Key evolution includes narrowing to high-growth middle-market consumer and industrial firms post-spinout, with recent funds like CCMP IV (over $500M target, closed recently) prioritizing North American platforms with 10%+ growth and $15-50M EBITDA.[4]
CCMP Capital rides the wave of middle-market consolidation and digital transformation in consumer and industrial sectors, capitalizing on resilient, cash-generative businesses amid economic volatility and supply chain shifts.[4] Timing aligns with post-pandemic growth in platforms like car washes (Mammoth Holdings) and residential exteriors (Omnia), fueled by market forces such as e-commerce acceleration, pricing power recovery, and accretive M&A opportunities in fragmented industries.[1][4] The firm influences the ecosystem by scaling founder-led companies through add-ons and operational tweaks, enhancing exit potential (e.g., IPOs) and bridging public-private gaps, while its J.P. Morgan legacy provides deal flow and expertise in healthcare/energy crossovers.[2][3]
CCMP is poised to expand via CCMP IV's remaining platforms (~2 more investments), leveraging its growth mandate amid rising demand for flexible capital in consumer/industrial tech-enabled firms.[4] Trends like AI-driven operations, sustainable industrials, and consumer resilience will shape its path, potentially boosting AUM through new funds amid PE dry powder. Its influence may evolve toward deeper tech integrations, sustaining middle-market leadership as it delivers on long-term missions from its banking heritage.[3][4] This positions CCMP as a steady force in value creation, echoing its origins in disciplined, high-conviction investing.